AP NEWS

U.S. Pharmaceutical Sterility Testing Market to 2025 by Type (In-house, Outsourced), Test Type (Bacterial Endotoxin, Sterility), End Use, Sample and Segment Forecasts - ResearchAndMarkets.com

November 7, 2018

DUBLIN--(BUSINESS WIRE)--Nov 7, 2018--The “U.S. Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type (In-house, Outsourced), By Test Type (Bacterial Endotoxin, Sterility), By End Use, By Sample, And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.

The U.S. pharmaceutical sterility testing market size is expected to reach USD 713.6 million by 2025 and is anticipated to expand at a CAGR of 11.3% over the forecast period.

Supportive government investment in healthcare industry, increasing R&D activities, and drug launches are the key factors driving market growth.

The government is keen on bringing down healthcare costs which is anticipated to encourage the U.S. Food and Drug Administration (FDA) to promote fast approvals of generic pharmaceuticals. Faster approvals drive the need for newer sterility testing methods. This is anticipated to encourage market participants to spend more on sterility solutions and in turn, expand the market. With increasing demand for drugs, companies are launching newer drugs with different routes of administration, dosage, and indication. These launches require thorough sterility testing and thus, are anticipated to drive market growth.

On the basis of type, the U.S. pharmaceutical sterility testing market is segmented into in-house and outsourcing. Most market players prefer outsourcing sterility testing services, as it is economically viable. Companies shortlist and select outsourcing firms based on their experience, expertise, and quality of service. Hence, it is difficult for new players to enter into this area.

Companies active in the U.S. pharmaceutical sterility testing market are Charles River Laboratories, Pace Analytical Series LLC, DynaLabs, Infinity, Boston Analytical, and others. Market players employ various growth strategies such as mergers, capacity expansion, and venturing into new regions.

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 U.S. Pharmaceutical Sterility Testing Market: Variables, Trends & Scope

Chapter 4 U.S. Pharmaceutical Sterility Testing Market: Type Estimates & Trend Analysis

Chapter 5 U.S. Pharmaceutical Sterility Testing Market: Test Type Estimates & Trend Analysis

Chapter 6 U.S. Pharmaceutical Sterility Testing Market: End-use Estimates & Trend Analysis

Chapter 7 U.S. Pharmaceutical Sterility Testing Market: Sample Estimates & Trend Analysis

Chapter 8 Regional Estimates & Trend Analysis, by Type, Test type, Sample, End-use

Chapter 9 Competitive Landscape

Pacific Biolabs STERIS Corporation. Boston Analytical Gibraltar Laboratories Infinity Laboratories Dynalabs SGS SA Toxikon, Inc. Pace Analytical Services LLC Charles River Laboratories International, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/577sc8/u_s?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005527/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pharmaceutical Manufacturing

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/07/2018 08:55 AM/DISC: 11/07/2018 09:34 AM

http://www.businesswire.com/news/home/20181107005527/en

AP RADIO
Update hourly